Healthcare

AstraZeneca and Oracle Begin Abu Dhabi AI Clinical-Trial Project

The collaboration’s first project is expected to support hypertension research in Abu Dhabi through M42.

The available results identify the Abu Dhabi component of the Oracle-AstraZeneca collaboration, but do not provide a separate GCC news article. The initiative will use AI and real-world data to help clinicians identify eligible patients earlier for clinical trials. Oracle contributes cloud, health-data, analytics, and workflow technology, while AstraZeneca contributes pharmaceutical and clinical expertise. Its practical focus is improving recruitment efficiency and connecting patients with relevant studies.

Original source: Ground News

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI